Membrane-mediated neuroprotection by curcumin from amyloid-β-peptide- induced toxicity

Langmuir

Volumn 29, Issue 37, 2013, Pages 11713-11723

  Thapa, Arjun ^a   Vernon, Briana C ^a   De La Peña, Karen ^b   Soliz, Gregory ^a   Moreno, Hector A ^c   López, Gabriel P ^a,d   Chi, Eva Y ^a  

^a MSC01 1070   (United States)

^b Florida International University   (United States)

^c Princeton University   (United States)

^d Duke University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIR/WATER INTERFACES; ALZHEIMER'S DISEASE; HUMAN NEUROBLASTOMA; MEMBRANE INTERACTIONS; MEMBRANE PROPERTIES; MOLECULAR MECHANISM; NEUROPROTECTIVE EFFECTS; THERAPEUTIC STRATEGY;

CELL DEATH; DYES; GLYCOPROTEINS; MEMBRANES; MONOLAYERS; OLIGOMERS; PATHOLOGY; PEPTIDES;

TOXICITY;

AMYLOID BETA PROTEIN; CURCUMIN; NEUROPROTECTIVE AGENT;

ARTICLE; CELL MEMBRANE; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; NERVE CELL; PATHOLOGY; STRUCTURE ACTIVITY RELATION; TUMOR CELL CULTURE;

AMYLOID BETA-PEPTIDES; CELL MEMBRANE; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; NEURONS; NEUROPROTECTIVE AGENTS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 84884263393     PISSN: 07437463     EISSN: 15205827     Source Type: Journal    
DOI: 10.1021/la4020459     Document Type: Article

References (60)

1. Haass, C.; Hung, A. Y.; Schlossmacher, M. G.; Oltersdorf, T.; Teplow, D. B.; Selkoe, D. J. Normal cellular processing of the beta-amyloid precursor protein results in the secretion of the amyloid beta peptide and related molecules Ann. N.Y. Acad. Sci. 1993, 695, 109-116 (Pubitemid 23348246)
2. Yang, F.; Lim, G. P.; Begum, A. N.; Ubeda, O. J.; Simmons, M. R.; Ambegaokar, S. S.; Chen, P. P.; Kayed, R.; Glabe, C. G.; Frautschy, S. A.; Cole, G. M. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo J. Biol. Chem. 2005, 280, 5892-5901 (Pubitemid 40280072)
3. Westman-Brinkmalm, A.; Ruetschi, U.; Portelius, E.; Andreasson, U.; Brinkmalm, G.; Karlsson, G.; Hansson, S.; Zetterberg, H.; Blennow, K. Proteomics/peptidomics tools to find CSF biomarkers for neurodegenerative diseases Front. Biosci. 2009, 14, 1793-1806
4. Vestergaard, M.; Hamada, T.; Takagi, M. Using model membranes for the study of amyloid beta:lipid interactions and neurotoxicity Biotechnol. Bioeng. 2008, 99, 753-763 (Pubitemid 351316617)
5. Walsh, D. M.; Selkoe, D. J. A beta oligomers-a decade of discovery J. Neurochem. 2007, 101, 1172-1184
6. Demuro, A.; Mina, E.; Kayed, R.; Milton, S. C.; Parker, I.; Glabe, C. G. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers J. Biol. Chem. 2005, 280, 17294-17300 (Pubitemid 41389198)
7. Deshpande, A.; Mina, E.; Glabe, C.; Busciglio, J. Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons J. Neurosci. 2006, 26, 6011-6018 (Pubitemid 44318367)
8. Simakova, O.; Arispe, N. J. The cell-selective neurotoxicity of the Alzheimer's Abeta peptide is determined by surface phosphatidylserine and cytosolic ATP levels. Membrane binding is required for Abeta toxicity J. Neurosci. 2007, 27, 13719-13729 (Pubitemid 350278273)
9. Sun, X. D.; Mo, Z. L.; Taylor, B. M.; Epps, D. E. A slowly formed transient conformer of A beta(1-40) is toxic to inward channels of dissociated hippocampal and cortical neurons of rats Neurobiol. Dis. 2003, 14, 567-578 (Pubitemid 37543534)
10. Arispe, N.; Diaz, J. C.; Flora, M. Efficiency of histidine-associating compounds for blocking the alzheimer's Abeta channel activity and cytotoxicity Biophys. J. 2008, 95, 4879-4889
11. Arispe, N.; Pollard, H. B.; Rojas, E. Giant multilevel cation channels formed by Alzheimer-disease amyloid beta-protein [a-beta-P-(1-40)] in bilayer-membranes Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 10573-10577 (Pubitemid 23347084)
12. 2+- channel hypothesis for neuronal death in Alzheimer-disease J. Gen. Physiol. 1994, 104, A31-A32
13. 2+ channels provides a mechanism for neuronal death in Alzheimer's disease Ann. N.Y. Acad. Sci. 1994, 747, 256-266
14. (2+)- channel hypothesis for neuronal death in Alzheimer disease Mol. Cell. Biochem. 1994, 140, 119-125
15. Arispe, N.; Rojas, E.; Pollard, H. B. Alzheimer-disease amyloid beta-protein forms calcium channels in bilayer-membranes-blockade by tromethamine and aluminum Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 567-571 (Pubitemid 23028904)
16. Tofoleanu, F.; Buchete, N. V. Alzheimer Abeta peptide interactions with lipid membranes: fibrils, oligomers and polymorphic amyloid channels Prion 2012, 6, 339-345
17. Jang, H.; Connelly, L.; Arce, F. T.; Ramachandran, S.; Kagan, B. L.; Lal, R.; Nussinov, R. Mechanisms for the insertion of toxic, fibril-like beta-amyloid oligomers into the membrane J. Chem. Theory Comput. 2013, 9, 822-833
18. Milanesi, L.; Sheynis, T.; Xue, W. F.; Orlova, E. V.; Hellewell, A. L.; Jelinek, R.; Hewitt, E. W.; Radford, S. E.; Saibil, H. R. Direct three-dimensional visualization of membrane disruption by amyloid fibrils Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 20455-20460
19. Kinnunen, P. K. J. Amyloid formation on lipid membrane surfaces Open Biol. J. 2009, 2, 163-175
20. Arispe, N.; Pollard, H. B.; Rojas, E. Giant multilevel cation channels formed by Alzheimer-disease amyloid beta-protein a-beta-P-(1-40) in bilayer-membranes Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 10573-10577 (Pubitemid 23347084)
21. Kayed, R.; Sokolov, Y.; Edmonds, B.; McIntire, T. M.; Milton, S. C.; Hall, J. E.; Glabe, C. G. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases J. Biol. Chem. 2004, 279, 46363-46366 (Pubitemid 39518276)
22. Sokolov, Y.; Kozak, J. A.; Kayed, R.; Chanturiya, A.; Glabe, C.; Hall, J. E. Soluble amyloid oligomers increase bilayer conductance by altering dielectric structure J. Gen. Physiol. 2006, 128, 637-647 (Pubitemid 44833376)
23. Chi, E. Y.; Ege, C.; Winans, A.; Majewski, J.; Wu, G.; Kjaer, K.; Lee, K. Y. Lipid membrane templates the ordering and induces the fibrillogenesis of Alzheimer's disease amyloid-beta peptide Proteins 2008, 72, 1-24 (Pubitemid 351809143)
24. Chi, E. Y.; Frey, S. L.; Lee, K. Y. C. Ganglioside GM1-mediated amyloid-beta fibrillogenesis and membrane disruption Biochemistry 2007, 46, 1913-1924
25. Ege, C.; Lee, K. Y. C. Insertion of Alzheimer's A beta 40 peptide into lipid monolayers Biophys. J. 2004, 87, 1732-1740 (Pubitemid 39167029)
26. Baldwin, A. J.; Knowles, T. P.; Tartaglia, G. G.; Fitzpatrick, A. W.; Devlin, G. L.; Shammas, S. L.; Waudby, C. A.; Mossuto, M. F.; Meehan, S.; Gras, S. L.; Christodoulou, J.; Anthony-Cahill, S. J.; Barker, P. D.; Vendruscolo, M.; Dobson, C. M. Metastability of native proteins and the phenomenon of amyloid formation J. Am. Chem. Soc. 2011, 133, 14160-14163
27. Kodali, R.; Wetzel, R. Polymorphism in the intermediates and products of amyloid assembly Curr. Opin. Struct. Biol. 2007, 17, 48-57 (Pubitemid 46242190)
28. Thirumalai, D.; Reddy, G. Protein thermodynamics: are native proteins metastable? Nat. Chem. 2011, 3, 910-911
29. Ganguli, M.; Dodge, H. H.; Chen, P.; Belle, S.; DeKosky, S. T. Ten-year incidence of dementia in a rural elderly US community population: the MoVIES Project Neurology 2000, 54, 1109-1116 (Pubitemid 30151854)
30. Ramassamy, C. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets Eur. J. Pharmacol. 2006, 545, 51-64
31. Ahmed, T.; Enam, S. A.; Gilani, A. H. Curcuminoids enhance memory in an amyloid-infused rat model of Alzheimer's disease Neuroscience 2010, 169, 1296-1306
32. Ahmed, T.; Gilani, A. H.; Hosseinmardi, N.; Semnanian, S.; Enam, S. A.; Fathollahi, Y. Curcuminoids rescue long-term potentiation impaired by amyloid peptide in rat hippocampal slices Synapse 2011, 65, 572-582
33. Caesar, I.; Jonson, M.; Nilsson, K. P.; Thor, S.; Hammarstrom, P. Curcumin promotes A-beta fibrillation and reduces neurotoxicity in transgenic Drosophila PLoS One 2012, 7, e31424
34. Park, S. Y.; Kim, H. S.; Cho, E. K.; Kwon, B. Y.; Phark, S.; Hwang, K. W.; Sul, D. Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation Food Chem. Toxicol. 2008, 46, 2881-2887
35. Qin, X. Y.; Cheng, Y.; Yu, L. C. Potential protection of curcumin against intracellular amyloid beta-induced toxicity in cultured rat prefrontal cortical neurons Neurosci. Lett. 2010, 480, 21-24
36. Thapa, A.; Woo, E. R.; Chi, E. Y.; Sharoar, M. G.; Jin, H. G.; Shin, S. Y.; Park, I. S. Biflavonoids are superior to monoflavonoids in inhibiting amyloid-beta toxicity and fibrillogenesis via accumulation of nontoxic oligomer-like structures Biochemistry 2011, 50, 2445-2455
37. Zhou, H.; Beevers, C. S.; Huang, S. The targets of curcumin Curr. Drug Targets 2011, 12, 332-347
38. Hamaguchi, T.; Ono, K.; Yamada, M. Curcumin and Alzheimer's Disease CNS Neurosci Ther. 2010, 16, 285-297
39. Ono, K.; Hasegawa, K.; Naiki, H.; Yamada, M. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro J. Neurosci. Res. 2004, 75, 742-750 (Pubitemid 38296087)
40. Wong, H.; Qi, W.; Choi, H.; Fermandez, E.; Kwon, I. A safe, blood-brain barrier permeable triphenylmethane dye inhibits amyloid-beta neurotoxicity by gnerating nontoxic aggregates ACS Chem. Neurosci. 2012, 2, 645-657
41. Ollila, F.; Halling, K.; Vuorela, P.; Vuorela, H.; Slotte, J. P. Characterization of flavonoid - biomembrane interactions Arch. Biochem. Biophys. 2002, 399, 103-108
42. Shishodia, S.; Sethi, G.; Aggarwal, B. B. Curcumin: getting back to the roots Ann. N.Y. Acad. Sci. 2005, 1056, 206-217 (Pubitemid 43030979)
43. Arora, A.; Byrem, T. M.; Nair, M. G.; Strasburg, G. M. Modulation of liposomal membrane fluidity by flavonoids and isoflavonoids Arch. Biochem. Biophys. 2000, 373, 102-109 (Pubitemid 30046494)
44. Erlejman, A. G.; Verstraeten, S. V.; Fraga, C. G.; Oteiza, P. I. The interaction of flavonoids with membranes: potential determinant of flavonoid antioxidant effects Free Radical Res. 2004, 38, 1311-1320 (Pubitemid 40045483)
45. Oteiza, P. I.; Erlejman, A. G.; Verstraeten, S. V.; Keen, C. L.; Fraga, C. G. Flavonoid-membrane interactions: a protective role of flavonoids at the membrane surface? Clin. Dev. Immunol. 2005, 12, 19-25 (Pubitemid 41647026)
46. Sirk, T. W.; Brown, E. F.; Sum, A. K.; Friedman, M. Molecular dynamics study on the biophysical interactions of seven green tea catechins with lipid bilayers of cell membranes J. Agric. Food Chem. 2008, 56, 7750-7758
47. Barry, J.; Fritz, M.; Brender, J. R.; Smith, P. E.; Lee, D. K.; Ramamoorthy, A. Determining the effects of lipophilic drugs on membrane structure by solid-state NMR spectroscopy: the case of the antioxidant curcumin J. Am. Chem. Soc. 2009, 131, 4490-4498
48. Sun, Y.; Lee, C. C.; Hung, W. C.; Chen, F. Y.; Lee, M. T.; Huang, H. W. The bound states of amphipathic drugs in lipid bilayers: study of curcumin Biophys. J. 2008, 95, 2318-2324
49. Sciarretta, K. L.; Gordon, D. J.; Petkova, A. T.; Tycko, R.; Meredith, S. C. Ab40-Lactam(D23/J28) models a conformation highly favorable for nucleation of amyloid Biochemistry 2005, 44, 6003-6014 (Pubitemid 40570694)
50. Ege, C.; Lee, K. Y. Insertion of Alzheimer's A beta 40 peptide into lipid monolayers Biophys. J. 2004, 87, 1732-1740 (Pubitemid 39167029)
51. Chi, E. Y.; Frey, S. L.; Lee, K. Y. Ganglioside G(M1)-mediated amyloid-beta fibrillogenesis and membrane disruption Biochemistry 2007, 46, 1913-1924
52. Piyasena, M. E.; Zeineldin, R.; Fenton, K.; Buranda, T.; Lopez, G. P. Biosensors based on release of compounds upon disruption of lipid bilayers supported on porous microspheres Biointerphases 2008, 3, 38
53. Hetenyi, C.; Szabo, Z.; Klement, E.; Datki, Z.; Kortvelyesi, T.; Zarandi, M.; Penke, B. Pentapeptide amides interfere with the aggregation of beta-amyloid peptide of Alzheimer's disease Biochem. Biophys. Res. Commun. 2002, 292, 931-936 (Pubitemid 34687294)
54. Rauk, A. Why is the amyloid beta peptide of Alzheimer's disease neurotoxic? Dalton Trans 2008, 1273-1282 (Pubitemid 351311808)
55. Thapa, A.; Shahnawaz, M.; Karki, P.; Raj Dahal, G.; Golam Sharoar, M.; Yub Shin, S.; Sup Lee, J.; Cho, B.; Park, I. S. Purification of inclusion body-forming peptides and proteins in soluble form by fusion to Escherichia coli thermostable proteins Biotechniques 2008, 44, 787-796 (Pubitemid 351839147)
56. Chi, E. Y.; Frey, S. L.; Winans, A.; Lam, K. L.; Kjaer, K.; Majewski, J.; Lee, K. Y. Amyloid-beta fibrillogenesis seeded by interface-induced peptide misfolding and self-assembly Biophys. J. 2010, 98, 2299-2308
57. + ions: the Langmuir technique study Biochim. Biophys. Acta, Biomembr. 2011, 1808, 2706-2713
58. Costin, I. S.; Barnes, G. T. Two-component monolayers II: surface pressure-area for teh octadecanol-docosyl sulphate system J. Colloid Interface Sci. 1975, 51, 106-121
59. Dynarowicz-Latka, P.; Kita, K. Molecular interaction in mixed monolayers at the air/water interface Adv. Colloid Interface Sci. 1999, 79, 1-17 (Pubitemid 128636641)
60. Gzyl-Malcher, B.; Handzlik, J.; Klekowska, E. Interaction of prazosin with model membranes-a Langmuir monolayer study Bioelectrochemistry 2012, 87, 96-103